We are live on ! Find out more
LAB icon

Standard BioTools

106 hedge funds and large institutions have $306M invested in Standard BioTools in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $20M | Put options by funds: $9.99M

22% more capital invested

Capital invested by funds: $252M → $306M (+$54.2M)

3% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 30

3% less funds holding

Funds holding: 109106 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
106
Holders Change
-3
Holders Change %
-2.75%
% of All Funds
2.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
29
Reduced
30
Closed
22
Calls
$20M
Puts
$9.99M
Net Calls
+$9.99M
Net Calls Change
+$4.85M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$2.22M +$427K +43,488 +27%
Lord, Abbett & Co
27
Lord, Abbett & Co
New Jersey
$2.21M +$2.01M +204,558 New
FC
28
FIC Capital
New York
$2.04M
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.99M -$22.3K -2,266 -1%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.82M +$108K +10,977 +7%
Norges Bank
31
Norges Bank
Norway
$1.77M
GTC
32
Ghost Tree Capital
New York
$1.62M +$1.47M +150,000 New
TCIM
33
TIAA CREF Investment Management
New York
$1.2M
Ameriprise
34
Ameriprise
Minnesota
$1.16M +$1.05M +106,861 New
BIM
35
BlackRock Investment Management
Delaware
$1.1M +$9.06K +923 +0.9%
Marshall Wace
36
Marshall Wace
United Kingdom
$1.04M +$949K +96,680 New
Macquarie Group
37
Macquarie Group
Australia
$998K +$907K +92,360 New
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$968K +$879K +89,473 New
Charles Schwab
39
Charles Schwab
California
$944K +$20.4K +2,080 +2%
ARTA
40
A.R.T. Advisors
New York
$914K -$65.2K -6,644 -7%
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$886K
Principal Financial Group
42
Principal Financial Group
Iowa
$856K
CS
43
Candriam SCA
Luxembourg
$854K +$216K +22,000 +39%
OPPM
44
Opus Point Partners Management
New York
$757K +$540K +55,000 +367%
Federated Hermes
45
Federated Hermes
Pennsylvania
$755K +$408K +41,567 +147%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$721K
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$577K +$9.71K +989 +2%
PC
48
Polar Capital
United Kingdom
$548K +$261K +26,622 +110%
DTL
49
Dynamic Technology Lab
Singapore
$545K +$495K +50,419 New
Connor, Clark & Lunn Investment Management (CC&L)
50
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$535K +$486K +49,450 New

LAB Hedge Fund Activity: Q4 2015 in Review

106 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2015, worth a combined $306M — up 22% from $252M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 19 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 29 added.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $17.6M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $16.2M sold.

  • 106 institutional investors held Standard BioTools (LAB) as of Q4 2015, down from 109 in Q3 2015.
  • Funds reported $306M of Standard BioTools stock for Q4 2015, up 22% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q4 2015 and 22 closed out, a net change of -3 holders.
  • The largest Standard BioTools buyer in Q4 2015 was Columbia Wanger Asset Management, an estimated $17.6M added.
  • The largest Standard BioTools seller in Q4 2015 was JP Morgan Chase, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2015.